medigraphic.com
ISSN 2078-7170 (Electronic)

2015, Number 2

<< Back Next >>

CorSalud 2015; 7 (2)

Characterization of beta blocker consumption in a pharmacy of an urban area

Alfonso HA, Pedraza GLM, Cabrera AD

Language: Spanish
References: 17
Page: 117-122
PDF size: 322.54 Kb.


ABSTRACT

Introduction: Hypertension has a high prevalence as the cause of frequent consultation. This disease is the main risk factor for cerebrovascular disease and beta blockers are a mainstay of its treatment.
Objective: To characterize the use of these drugs in the hypertensive population of a pharmacy in an urban area.
Method: A descriptive cross-sectional study was carried out at Pharmacy 6.76, in Santa Clara, Villa Clara, Cuba, from October to December 2013.
Results: The main results showed a predominance of beta blocker consumption in women (53.4%), in the age group of 50-64 years (48.9%), and the most commonly used drug was atenolol (93.2%). Its predominant daily dose was 1 tablet (68.3%); and 2 tablets of propranolol (50.0%). The most commonly associated drugs were diuretics and angiotensin-converting enzyme inhibitors.
Conclusions: Atenolol was the most commonly used beta blocker in this research, and it was often associated with diuretics and angiotensin-converting enzyme inhibitors. There was a predominance of female patients, aged 50-64 years and stage 2 hypertension.


REFERENCES

  1. Furones Mourelle JA. Hipertensión arterial. En: Morón Rodríguez F, ed. Farmacología Clínica. Vol I. La Habana: Editorial Ciencias Médicas; 2009. p.133-158.

  2. Hernandez-Vila E. A Review of the JNC 8 Blood Pressure Guideline. Tex Heart Inst J. 2015;42:226-8.

  3. Pérez Caballero MD, Dueñas Herrera A, Alfonso Guerra JP, Vásquez Vigoa A, Navarro Despaigne D, Hernández Cueto M, et al. Hipertensión arterial. Guía para la prevención, diagnóstico y tratamiento. Comisión Nacional Técnica Asesora del Programa de Hipertensión arterial. La Habana: Editorial Cien-cias Médicas; 2008.

  4. Morales Salinas A. Dogmas y actualidades del uso de los beta-bloqueadores en prevención secunda-ria. Primera parte. Finlay [Internet]. 2011 [citado 13 Sep 2014];1:[aprox. 6 p]. Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/47/1212

  5. Kuyper LM, Khan NA. Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis. Can J Cardiol. 2014;30:S47-53.

  6. Testa G, Cacciatore F, Della-Morte D, Mazzella F, Mastrobuoni C, Galizia G, et al. Atenolol use is associated with long-term mortality in community-dwelling older adults with hypertension. Geriatr Gerontol Int. 2014;14:153-8.

  7. Arredondo Bruce A. Beta-bloqueadores en la hiper-tensión arterial: ¿podemos descartarlos? AMC [In-ternet]. 2010 [citado 20 Sep 2014];14:[aprox. 11 p.]. Disponible en: http://www.revistaamc.sld.cu/index.php/amc/article/view/2248/683

  8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detec-tion, Evaluation, and Treatment of High Blood Pres-sure: the JNC 7 report. JAMA. 2003;289:2560-72.

  9. Ong HT. Beta blockers in hypertension and cardio-vascular disease. BMJ. 2007;334:946-9.

  10. Groning Roque E, García Fernández R, García Barre-to D. Control ambulatorio de la presión arterial en pacientes blancos y negros con cardiopatía isqué-mica asociada. Rev Cubana Med [Internet]. 2009 [citado 20 Sep 2014];48:193-203. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232009000400007&lng=es&nrm=iso&tlng=es

  11. Mederos Ávila ME, Casas Fernández JA, Mederos Ávila JA, Tabares Navarro CL, Chaveco Bautista G. Comportamiento de pacientes con hipertensión arterial atendidos en servicios de urgencia del Policlínico "José Martí Pérez". MEDISAN [Internet]. 2011 [citado 20 Sep 2014];15: 636-42. Disponible en: http://scielo.sld.cu/pdf/san/v15n5/san10511.pdf

  12. Llanio Navarro R, Perdomo González G. Propedéutica Clínica y Semiología Médica. TI. La Habana: Ecimed; 2003. p 627-632.

  13. Melia Pérez D, Castañeda Abascal IE, Pulles Cuervo JC. Caracterización de pacientes hipertensos no dispensarizados que acuden a un servicio de urgencias. Rev Cubana Salud Pública [Internet]. 2009 [citado 20 Sep 2014];35:128-38. Disponible en: http://scielo.sld.cu/pdf/rcsp/v35n4/spu12409.pdf

  14. Alfonso Calderón E, Pizarro Herrera C. Caracterización de la hipertensión arterial en el adulto mayor en el municipio Villalba, Nueva Esparta, Venezuela. 2006. Rev Med Electrón [Internet]. 2010 [citado 22 Sep 2014];32:[aprox. 7 p.]. Disponible en: http://scielo.sld.cu/pdf/rme/v32n4/spu02410.pdf

  15. Alfonso Orta I, Alonso Carbonell l, Alonso Galván P, Calvo Barbado DM, Cruz barrios MA, Delgado Martínez I, et al. Formulario nacional de medicamentos [Internet]. La Habana: ECIMED; 2011 [citado 28 Ago 2014]. Disponible en: http://www.bvs.sld.cu/libros_texto/formulario_me dicamentos/formulario_med_completo01.pdf

  16. Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH. Beta-blockers for hypertension. Cochrane Database Syst Rev [Internet]. 2012 [citado 22 Ago 2014];11:CD002003. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/14651 858.CD002003.pub4/epdf

  17. Cabrera Cepero JR. Análisis del consumo de inhibidores de la enzima convertidora de angiotensina en el territorio oeste de La Habana, 2005-2009. Rev Cubana Farm [Internet]. 2011 [citado 22 Ago 2014]; 45:524-35. Disponible en: http://scielo.sld.cu/pdf/far/v45n4/far07411.pdf




2020     |     www.medigraphic.com